123 related articles for article (PubMed ID: 31996889)
1. Switching enzyme activity by a temperature responsive inhibitor modified polymer.
Rottke FO; Heyne MV; Reinicke S
Chem Commun (Camb); 2020 Feb; 56(16):2459-2462. PubMed ID: 31996889
[TBL] [Abstract][Full Text] [Related]
2. Homodimeric tacrine congeners as acetylcholinesterase inhibitors.
Hu MK; Wu LJ; Hsiao G; Yen MH
J Med Chem; 2002 May; 45(11):2277-82. PubMed ID: 12014965
[TBL] [Abstract][Full Text] [Related]
3. Development of tacrine clusters as positively cooperative systems for the inhibition of acetylcholinesterase.
Evangelista TCS; López Ó; Ferreira SB; Fernández-Bolaños JG; Sydnes MO; Lindbäck E
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1659-1664. PubMed ID: 34294013
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Biological Evaluation of New Tacrine Analogues under Microwave Irradiation.
Alshareef HF; Mohamed HAEH; Salaheldin AM
Chem Pharm Bull (Tokyo); 2017; 65(8):732-738. PubMed ID: 28768927
[TBL] [Abstract][Full Text] [Related]
5. [Design, synthesis and evaluation of tacrine-methoxybenzene hybrids as cholinesterases inhibitors].
Luo W; Zhao YM; Zhang Z; Su YB; Wang CJ
Yao Xue Xue Bao; 2012 Jul; 47(7):916-21. PubMed ID: 22993857
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Shao D; Zou C; Luo C; Tang X; Li Y
Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
[TBL] [Abstract][Full Text] [Related]
7. Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions.
Carlier PR; Chow ES; Han Y; Liu J; El Yazal J; Pang YP
J Med Chem; 1999 Oct; 42(20):4225-31. PubMed ID: 10514292
[TBL] [Abstract][Full Text] [Related]
8. Tacrine based human cholinesterase inhibitors: synthesis of peptidic-tethered derivatives and their effect on potency and selectivity.
Butini S; Guarino E; Campiani G; Brindisi M; Coccone SS; Fiorini I; Novellino E; Belinskaya T; Saxena A; Gemma S
Bioorg Med Chem Lett; 2008 Oct; 18(19):5213-6. PubMed ID: 18786825
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of tacrine-thiadiazolidinone hybrids as dual acetylcholinesterase inhibitors.
Dorronsoro I; Alonso D; Castro A; del Monte M; García-Palomero E; Martínez A
Arch Pharm (Weinheim); 2005 Jan; 338(1):18-23. PubMed ID: 15674800
[TBL] [Abstract][Full Text] [Related]
10. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
[TBL] [Abstract][Full Text] [Related]
11. Novel tacrine derivatives exhibiting improved acetylcholinesterase inhibition: Design, synthesis and biological evaluation.
Reddy EK; Remya C; Mantosh K; Sajith AM; Omkumar RV; Sadasivan C; Anwar S
Eur J Med Chem; 2017 Oct; 139():367-377. PubMed ID: 28810188
[TBL] [Abstract][Full Text] [Related]
12. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF
Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
Pourabdi L; Khoobi M; Nadri H; Moradi A; Moghadam FH; Emami S; Mojtahedi MM; Haririan I; Forootanfar H; Ameri A; Foroumadi A; Shafiee A
Eur J Med Chem; 2016 Nov; 123():298-308. PubMed ID: 27484515
[TBL] [Abstract][Full Text] [Related]
14. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
El-Malah A; Gedawy EM; Kassab AE; Salam RM
Arch Pharm (Weinheim); 2014 Feb; 347(2):96-103. PubMed ID: 24343873
[TBL] [Abstract][Full Text] [Related]
15. Bis(7)-tacrine derivatives as multitarget-directed ligands: Focus on anticholinesterase and antiamyloid activities.
Bolognesi ML; Bartolini M; Mancini F; Chiriano G; Ceccarini L; Rosini M; Milelli A; Tumiatti V; Andrisano V; Melchiorre C
ChemMedChem; 2010 Aug; 5(8):1215-20. PubMed ID: 20486153
[No Abstract] [Full Text] [Related]
16. Synthesis and functional survey of new Tacrine analogs modified with nitroxides or their precursors.
Kálai T; Altman R; Maezawa I; Balog M; Morisseau C; Petrlova J; Hammock BD; Jin LW; Trudell JR; Voss JC; Hideg K
Eur J Med Chem; 2014 Apr; 77():343-50. PubMed ID: 24657571
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the role of linker moieties in bifunctional tacrine hybrids.
Eckroat TJ; Green KD; Reed RA; Bornstein JJ; Garneau-Tsodikova S
Bioorg Med Chem; 2013 Jun; 21(12):3614-23. PubMed ID: 23535563
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationship (QSAR) of tacrine derivatives against acetylcholinesterase (AChE) activity using variable selections.
Jung M; Tak J; Lee Y; Jung Y
Bioorg Med Chem Lett; 2007 Feb; 17(4):1082-90. PubMed ID: 17158047
[TBL] [Abstract][Full Text] [Related]
20. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
